Successful Treatment of Iron Overload with Phlebotomies in Two Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II)

Autor: Ladislav Chrobák

Publikováno v: Acta Medica, Vol 49, Iss 3, Pp 193-195 (2006)

Successful treatment of iron overload by phlebotomies has been reported in two splenectomized siblings with congenital dyserythropoietic anemia – type II (CDA-II). In both patients 400 ml of blood were withdrawn every month. During three years 12 2

Externí odkaz: https://doaj.org/article/6f80e2ad98284662b8313ffe488601ed

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Autor: Liesbeth C. de Wreede, Jürgen Finke, Diderik Jan Eikema, Jorge Sierra, Yves Beguin, Gérard Socié, Achilles Anagnostopoulos, Zübeyde Nur Özkurt, Anja van Biezen, Tobias Gedde-Dahl, Guido Kobbe, Maija Itälä-Remes, Dietger Niederwieser, Linda Koster, Marie Robin, Theo de Witte, Pavel Jindra, Johan Maertens, Dimitris Ziagkos, Eline M. P. Cremers, Nicolaus Kröger, Dietrich W. Beelen, Arnon Nagler, Per Ljungman

Publikováno v: Cremers, E M P, de Witte, T, de Wreede, L, Eikema, D-J, Koster, L, van Biezen, A, Finke, J R, Socié, G, Beelen, D, Maertens, J, Nagler, A, Kobbe, G, Ziagkos, D, Itälä-Remes, M, Gedde-Dahl, T, Sierra, J, Niederwieser, D, Ljungman, P, Beguin, Y, Ozkurt, Z N, Anagnostopoulos, A, Jindra, P, Robin, M & Kröger, N 2019, ' A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation * ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2404-2414 . https://doi.org/10.1080/10428194.2019.1594215
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare

Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. This prospective non-interventional study evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea9ef9c193ca24bcb26cc9ed8891a9e1
https://pubmed.ncbi.nlm.nih.gov/30997844

Diabetes remission after bariatric surgery in obese patients with haemochromatosis

Autor: Jean-Michel Oppert, Christine Poitou, Jean-Luc Bouillot, F. Phan, Judith Aron-Wisnewsky, C. Vauloup-Soupault, Camille Vatier

Publikováno v: Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2017, ⟨10.1016/j.diabet.2017.02.005⟩
Diabetes and Metabolism, Elsevier Masson, 2017, 44 (2), pp.185-187. ⟨10.1016/j.diabet.2017.02.005⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2017, 44 (2), pp.185-187. ⟨10.1016/j.diabet.2017.02.005⟩
Diabetes and Metabolism, Elsevier Masson, 2017, 〈10.1016/j.diabet.2017.02.005〉

International audience; Haemochromatosis represents a common autosomal-recessive hereditary disease that induces iron overload [1]. The most frequent mutation results in a change of cysteine to tyrosine at position 282 (C282Y) in the HFE protein. HFE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c850e45c764656d95db5a32407fd34
https://hal.sorbonne-universite.fr/hal-01504520

Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis

Autor: René M.M. van Aerts, Ger H. Koek, Cees Th.B.M. van Deursen

Publikováno v: Clinical Gastroenterology and Hepatology, 14, 147-52
Clinical Gastroenterology and Hepatology, 14, 1, pp. 147-52
Clinical gastroenterology and hepatology, 14(1), 147-152. Elsevier Science

Item does not contain fulltext BACKGROUND & AIMS: Patients with hereditary hemochromatosis (HH) need frequent phlebotomies to reduce iron overload. Proton pump inhibitors (PPIs) were reported to reduce the need for phlebotomies in patients homozygous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bb5d185dd8e5a91379611b043a47fd
https://pubmed.ncbi.nlm.nih.gov/26383698

Anemia muy precoz del prematuro con peso ≤ 1 500 g:: prevalencia y factores asociados Very early anemia in premature weighing ≤ 1 500 g:: prevalence and associated factors

Autor: Yusleivy Milagros López Negrín, Tania Roig Álvarez

Publikováno v: Revista Cubana de Pediatría, Vol 82, Iss 2, p 0 (2010)

INTRODUCCIÓN. En el Hospital Ginecoobstétrico Docente «Ramón González Coro» no se ha estudiado la prevalencia de la anemia muy precoz de la prematuridad y los factores asociados a su aparición. Se decidió realizar esta investigación para dar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::db107100de7658e3b4905fc420746895
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312010000200004